Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-21-059985

Chief Financial Officer sold 10,000 shares at an average $32.41 ($324,050)

  • Chief Financial Officer acquired 10,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Cohen Chad M Chief Financial Officer 2021-10-05 Option exercise +5,000 $7.27 $36,350 26,604 D: show line 1 in the form
Cohen Chad M Chief Financial Officer 2021-10-05 Sale −5,000 $32.51 $162,550 21,604 D: show line 2 in the form
Cohen Chad M Chief Financial Officer 2021-10-06 Option exercise +5,000 $7.27 $36,350 26,604 D: show line 3 in the form
Cohen Chad M Chief Financial Officer 2021-10-06 Sale −5,000 $32.30 $161,500 21,604 D: show line 4 in the form
Open-market sales · 10,000 sh · avg $32.41 · $324,050

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Cohen Chad M Chief Financial Officer 2021-10-05 Option exercise · Stock Option (Right to Buy) −5,000 105,000 D: show line 5 in the form
Cohen Chad M Chief Financial Officer 2021-10-06 Option exercise · Stock Option (Right to Buy) −5,000 100,000 D: show line 6 in the form
Loading xslF345X03/doc4.xml…